Literature DB >> 33552000

Natural Compounds in Sex Hormone-Dependent Cancers: The Role of Triterpenes as Therapeutic Agents.

Codruţa Şoica1, Mirela Voicu1, Roxana Ghiulai1, Cristina Dehelean1, Roxana Racoviceanu1, Cristina Trandafirescu1, Oana-Janina Roșca1,2, Gabriela Nistor1, Marius Mioc1, Alexandra Mioc1.   

Abstract

Sex hormone-dependent cancers currently contribute to the high number of cancer-related deaths worldwide. The study and elucidation of the molecular mechanisms underlying the progression of these tumors was a double-edged sword, leading to the expansion and development of new treatment options, with the cost of triggering more aggressive, therapy resistant relapses. The interaction of androgen, estrogen and progesterone hormones with specific receptors (AR, ER, PR) has emerged as a key player in the development and progression of breast, ovarian, prostate and endometrium cancers. Sex hormone-dependent cancers share a common and rather unique carcinogenesis mechanism involving the active role of endogenous and exogenous sex hormones to maintain high mitotic rates and increased cell proliferation thus increasing the probability of aberrant gene occurrence and accumulation highly correlated with abnormal cell division and the occurrence of malignant phenotypes. Cancer related hormone therapy has evolved, currently being associated with the blockade of other signaling pathways often associated with carcinogenesis and tumor progression in cancers, with promising results. However, despite the established developments, there are still several shortcomings to be addressed. Triterpenes are natural occurring secondary metabolites biosynthesized by various pathways starting from squalene cyclization. Due to their versatile therapeutic potential, including the extensively researched antiproliferative effect, these compounds are most definitely a cornerstone in the research and development of new natural/semisynthetic anticancer therapies. The present work thoroughly describes the ongoing research related to the antitumor activity of triterpenes in sex hormone-dependent cancers. Also, the current review highlights both the biological activity of various triterpenoid compounds and their featured mechanisms of action correlated with important chemical structural features.
Copyright © 2021 Şoica, Voicu, Ghiulai, Dehelean, Racoviceanu, Trandafirescu, Roșca, Nistor, Mioc and Mioc.

Entities:  

Keywords:  antiproliferative activity; hormone-dependent cancers; phytocompounds; therapeutic agents; triterpenes

Mesh:

Substances:

Year:  2021        PMID: 33552000      PMCID: PMC7859451          DOI: 10.3389/fendo.2020.612396

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  164 in total

1.  Taraxastane inhibits the proliferation, migration and invasion of human cervical cancer by inducing ROS- mediated necrosis like cell death, cell cycle arrest and modulation of JNK/MAPK signaling pathway.

Authors:  Junbo Hu; Yanli Zhang; Peng Guo; Na Tang; Yanju Lu; Zhichun Jin
Journal:  J BUON       Date:  2020 Mar-Apr       Impact factor: 2.533

2.  Gypensapogenin H, a novel dammarane-type triterpene induces cell cycle arrest and apoptosis on prostate cancer cells.

Authors:  Xiao-Shu Zhang; Chen Zhao; Wei-zhuo Tang; Xiao-jun Wu; Yu-Qing Zhao
Journal:  Steroids       Date:  2015-10-26       Impact factor: 2.668

3.  Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.

Authors:  Sumana Dakeng; Suwit Duangmano; Weena Jiratchariyakul; Yaowalak U-Pratya; Oliver Bögler; Pimpicha Patmasiriwat
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

4.  Oldhamianoside II inhibits prostate cancer progression via regulation of EMT and the Wnt/β-catenin signaling pathway.

Authors:  Kaizhi Li; Xuemei Zhan; Jingyong Sun; Tianfeng Wang; Hongyan Dong; Fanbo Jing; Dongmei Li; Yu Cao; Yali Liu; Lin Wang; Shengnan Li
Journal:  Oncol Lett       Date:  2018-04-10       Impact factor: 2.967

Review 5.  Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments.

Authors:  Karina Valdés; Javier Morales; Lennin Rodríguez; Germán Günther
Journal:  Nanomedicine (Lond)       Date:  2016-11-04       Impact factor: 5.307

6.  Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.

Authors:  Dorrah Deeb; Xiaohua Gao; Hao Jiang; Scott A Dulchavsky; Subhash C Gautam
Journal:  Prostate       Date:  2009-06-01       Impact factor: 4.104

Review 7.  Review on anti-tumor effect of triterpene acid compounds.

Authors:  Weisan Zhang; Xiaoyan Men; Ping Lei
Journal:  J Cancer Res Ther       Date:  2014-08       Impact factor: 1.805

8.  Antiangiogenic properties of Koetjapic acid, a natural triterpene isolated from Sandoricum koetjaoe Merr.

Authors:  Zeyad D Nassar; Abdalrahim Fa Aisha; Mohamed Bk Ahamed; Zhari Ismail; Khalid M Abu-Salah; Salman A Alrokayan; Amin Malik Shah Abdul Majid
Journal:  Cancer Cell Int       Date:  2011-04-27       Impact factor: 5.722

9.  Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent.

Authors:  Dorrah Deeb; Xiaohua Gao; Yongbo Liu; Nadimpalli R S Varma; Ali S Arbab; Subhash C Gautam
Journal:  Molecules       Date:  2013-03-13       Impact factor: 4.411

10.  Anticancer effect of triterpenes from Ganoderma lucidum in human prostate cancer cells.

Authors:  Lijun Qu; Sumei Li; Yumin Zhuo; Jianfan Chen; Xiaoping Qin; Guoqing Guo
Journal:  Oncol Lett       Date:  2017-10-09       Impact factor: 2.967

View more
  6 in total

Review 1.  Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part I).

Authors:  Marius Mioc; Andreea Milan; Daniel Malița; Alexandra Mioc; Alexandra Prodea; Roxana Racoviceanu; Roxana Ghiulai; Andreea Cristea; Florina Căruntu; Codruța Șoica
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

Review 2.  Anticancer Potential of Betulonic Acid Derivatives.

Authors:  Adelina Lombrea; Alexandra Denisa Scurtu; Stefana Avram; Ioana Zinuca Pavel; Māris Turks; Jevgeņija Lugiņina; Uldis Peipiņš; Cristina Adriana Dehelean; Codruta Soica; Corina Danciu
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

Review 3.  The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges.

Authors:  Andreea Milan; Alexandra Mioc; Alexandra Prodea; Marius Mioc; Roxana Buzatu; Roxana Ghiulai; Roxana Racoviceanu; Florina Caruntu; Codruţa Şoica
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

Review 4.  Semisynthetic Derivatives of Pentacyclic Triterpenes Bearing Heterocyclic Moieties with Therapeutic Potential.

Authors:  Gabriela Nistor; Cristina Trandafirescu; Alexandra Prodea; Andreea Milan; Andreea Cristea; Roxana Ghiulai; Roxana Racoviceanu; Alexandra Mioc; Marius Mioc; Viviana Ivan; Codruța Șoica
Journal:  Molecules       Date:  2022-10-03       Impact factor: 4.927

5.  Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.

Authors:  Sebastian Simu; Iasmina Marcovici; Amadeus Dobrescu; Daniel Malita; Cristina Adriana Dehelean; Dorina Coricovac; Flavius Olaru; George Andrei Draghici; Dan Navolan
Journal:  Molecules       Date:  2021-05-08       Impact factor: 4.411

Review 6.  Influence of Olive Oil and Its Components on Breast Cancer: Molecular Mechanisms.

Authors:  Raquel Moral; Eduard Escrich
Journal:  Molecules       Date:  2022-01-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.